5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

 

Breast Cancer Management
16:29

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

NCCN Guidelines Update for ER+ Breast Cancer: CDK4/6 and PIK3CA Inhibitors for Advanced BC & Tamoxifen and Aromatase Inhibitors for Early BC

FEATURING Jame Abraham, William Gradishar
  • 9,370 views
  • September 13, 2019
  • 31
10:06

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

NCCN Guidelines Update for TNBC and HER2 Breast Cancer: Immunotherapy and PARP Inhibitors in TNBC & Trastuzumab Biosimilars in HER2 BC

FEATURING Jame Abraham, William Gradishar
  • 266 views
  • September 13, 2019
  • 1
18:20

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Review of HER2 Testing Guidelines in Breast Cancer With Cases - IHC Equivocal Definition, Repeating Testing if Initially Negative Test on Core Biopsy, & HER2 Genotypes

FEATURING David Hicks
  • 501 views
  • September 17, 2019
  • 1
08:27

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Therapeutic Options for Systemic Treatment of TNBC & New Data on PDL-1 and Immunotherapy

FEATURING David Hicks
  • 607 views
  • September 17, 2019
15:23

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Q&A on Clinical Data Behind Changing the Guidelines, Her2+ Testing in DCIS, Centromeric Probes, PDL-1 in TNBC, Changes in Fish Ratio & Heterogeneous HER2

FEATURING David Hicks
  • 210 views
  • September 17, 2019
  • 1
18:27

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Overview of Current Response Imaging Patterns to Immunotherapy

FEATURING Heather Jacene
  • 32 views
  • September 24, 2019
17:12

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Imaging Response to Treatment Challenges of Immunotherapy: Discussion of Patterns of Immune-Related Adverse Effects

FEATURING Heather Jacene
  • 23 views
  • September 24, 2019
29:47

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Current State of Breast Cancer Vaccines: Testing Vaccines in Adjuvant Setting, HER2 as a Target of Immune Response and Related Trials

FEATURING George Peoples
  • 116 views
  • September 24, 2019
09:46

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Current Concept of Breast Cancer Vaccines: Study on HER2 Directed Vaccine in Combo with HER2 Directed Trastuzumab & Checkpoint Inhibitors + Vaccines

FEATURING George Peoples
  • 68 views
  • September 24, 2019
24:47

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Current Standard of Care For Breast Cancer With Radiation Therapy: Can the Length of Radiation Treatment be Reduced & Does the Whole Breast Need to Be Irradiated?

FEATURING Frank Vicini
  • 231 views
  • September 24, 2019
  • 2
26:50

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

CAR-T Cell Therapy for Breast Cancer: Types of T-Cell Therapy, Identifying Target Cancer-Antigen, Mesothelin Directed CAR T Therapy & Saving T-Cells from Exhaustion

FEATURING Shanu Modi
  • 826 views
  • September 24, 2019
  • 4
16:01

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Evolving Strategies for Enhancing the Impact of Immunotherapy in TNBC: Role of TILs, PD-1/PD-L1 Blockade Mechanisms of Action, Available CPi Monotherapy Options

FEATURING Hope Rugo
  • 29 views
  • November 28, 2019
14:34

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Enhancing the Impact of IO in Metastatic / Locally Advanced TNBC: Atezolizumab + Nab-Paclitaxel Improved PFS and OS - Results of IMpassion130 Trial

FEATURING Hope Rugo
  • 35 views
  • November 28, 2019
05:41

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Enhancing the Impact of Immunotherapy in TNBC: IO Therapy Options in Early Stage Disease

FEATURING Hope Rugo
  • 27 views
  • November 28, 2019
08:55

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Improving the Response to Immunotherapy in TNBC - Trials in Metastatic and (Neo)Adjuvant Setting, Novel IO Combination Strategies, and Role in HER2+ / ER+ Disease

FEATURING Hope Rugo
  • 246 views
  • November 28, 2019